Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management

Pavol Zubor, Peter Kubatka, Karol Kajo, Zuzana Dankova, Hubert Polacek, Tibor Bielik, Erik Kudela, Marek Samec, Alena Liskova, Dominika Vlcakova, Tatiana Kulkovska, Igor Stastny, Veronika Holubekova, Jan Bujnak, Zuzana Laucekova, Dietrich Busselberg, Mariusz Adamek, Walther Kuhn, Jan Danko, Olga Golubnitschaja

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

In the global context, the epidemic of breast cancer (BC) is evident for the early 21st century. Evidence shows that national mammography screening programs have sufficiently reduced BC related mortality. Therefore, the great utility of the mammography-based screening is not an issue. However, both false positive and false negative BC diagnosis, excessive biopsies, and irradiation linked to mammography application, as well as sub-optimal mammography-based screening, such as in the case of high-dense breast tissue in young females, altogether increase awareness among the experts regarding the limitations of mammography-based screening. Severe concerns regarding the mammography as the "golden standard" approach demanding complementary tools to cover the evident deficits led the authors to present innovative strategies, which would sufficiently improve the quality of the BC management and services to the patient. Contextually, this article provides insights into mammography deficits and current clinical data demonstrating the great potential of non-invasive diagnostic tools utilizing circulating miRNA profiles as an adjunct to conventional mammography for the population screening and personalization of BC management.

Original languageEnglish
JournalInternational journal of molecular sciences
Volume20
Issue number12
DOIs
Publication statusPublished - 13 Jun 2019

Fingerprint

Breast Diseases
Mammography
Biopsy
Disease Management
MicroRNAs
breast
cancer
Breast Neoplasms
screening
Liquids
liquids
Screening
profiles
mortality
Breast
irradiation
Irradiation
Tissue
Mortality

Keywords

  • breast cancer
  • individualized patient profile
  • liquid biopsy
  • mammography
  • miRNA
  • multi-level diagnostics
  • omics
  • personalized medicine
  • predictive and preventive approach
  • screening

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management. / Zubor, Pavol; Kubatka, Peter; Kajo, Karol; Dankova, Zuzana; Polacek, Hubert; Bielik, Tibor; Kudela, Erik; Samec, Marek; Liskova, Alena; Vlcakova, Dominika; Kulkovska, Tatiana; Stastny, Igor; Holubekova, Veronika; Bujnak, Jan; Laucekova, Zuzana; Busselberg, Dietrich; Adamek, Mariusz; Kuhn, Walther; Danko, Jan; Golubnitschaja, Olga.

In: International journal of molecular sciences, Vol. 20, No. 12, 13.06.2019.

Research output: Contribution to journalReview article

Zubor, P, Kubatka, P, Kajo, K, Dankova, Z, Polacek, H, Bielik, T, Kudela, E, Samec, M, Liskova, A, Vlcakova, D, Kulkovska, T, Stastny, I, Holubekova, V, Bujnak, J, Laucekova, Z, Busselberg, D, Adamek, M, Kuhn, W, Danko, J & Golubnitschaja, O 2019, 'Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management', International journal of molecular sciences, vol. 20, no. 12. https://doi.org/10.3390/ijms20122878
Zubor, Pavol ; Kubatka, Peter ; Kajo, Karol ; Dankova, Zuzana ; Polacek, Hubert ; Bielik, Tibor ; Kudela, Erik ; Samec, Marek ; Liskova, Alena ; Vlcakova, Dominika ; Kulkovska, Tatiana ; Stastny, Igor ; Holubekova, Veronika ; Bujnak, Jan ; Laucekova, Zuzana ; Busselberg, Dietrich ; Adamek, Mariusz ; Kuhn, Walther ; Danko, Jan ; Golubnitschaja, Olga. / Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management. In: International journal of molecular sciences. 2019 ; Vol. 20, No. 12.
@article{e843558cdc904acb912e4f8864970526,
title = "Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management",
abstract = "In the global context, the epidemic of breast cancer (BC) is evident for the early 21st century. Evidence shows that national mammography screening programs have sufficiently reduced BC related mortality. Therefore, the great utility of the mammography-based screening is not an issue. However, both false positive and false negative BC diagnosis, excessive biopsies, and irradiation linked to mammography application, as well as sub-optimal mammography-based screening, such as in the case of high-dense breast tissue in young females, altogether increase awareness among the experts regarding the limitations of mammography-based screening. Severe concerns regarding the mammography as the {"}golden standard{"} approach demanding complementary tools to cover the evident deficits led the authors to present innovative strategies, which would sufficiently improve the quality of the BC management and services to the patient. Contextually, this article provides insights into mammography deficits and current clinical data demonstrating the great potential of non-invasive diagnostic tools utilizing circulating miRNA profiles as an adjunct to conventional mammography for the population screening and personalization of BC management.",
keywords = "breast cancer, individualized patient profile, liquid biopsy, mammography, miRNA, multi-level diagnostics, omics, personalized medicine, predictive and preventive approach, screening",
author = "Pavol Zubor and Peter Kubatka and Karol Kajo and Zuzana Dankova and Hubert Polacek and Tibor Bielik and Erik Kudela and Marek Samec and Alena Liskova and Dominika Vlcakova and Tatiana Kulkovska and Igor Stastny and Veronika Holubekova and Jan Bujnak and Zuzana Laucekova and Dietrich Busselberg and Mariusz Adamek and Walther Kuhn and Jan Danko and Olga Golubnitschaja",
year = "2019",
month = "6",
day = "13",
doi = "10.3390/ijms20122878",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Why the Gold Standard Approach by Mammography Demands Extension by Multiomics? Application of Liquid Biopsy miRNA Profiles to Breast Cancer Disease Management

AU - Zubor, Pavol

AU - Kubatka, Peter

AU - Kajo, Karol

AU - Dankova, Zuzana

AU - Polacek, Hubert

AU - Bielik, Tibor

AU - Kudela, Erik

AU - Samec, Marek

AU - Liskova, Alena

AU - Vlcakova, Dominika

AU - Kulkovska, Tatiana

AU - Stastny, Igor

AU - Holubekova, Veronika

AU - Bujnak, Jan

AU - Laucekova, Zuzana

AU - Busselberg, Dietrich

AU - Adamek, Mariusz

AU - Kuhn, Walther

AU - Danko, Jan

AU - Golubnitschaja, Olga

PY - 2019/6/13

Y1 - 2019/6/13

N2 - In the global context, the epidemic of breast cancer (BC) is evident for the early 21st century. Evidence shows that national mammography screening programs have sufficiently reduced BC related mortality. Therefore, the great utility of the mammography-based screening is not an issue. However, both false positive and false negative BC diagnosis, excessive biopsies, and irradiation linked to mammography application, as well as sub-optimal mammography-based screening, such as in the case of high-dense breast tissue in young females, altogether increase awareness among the experts regarding the limitations of mammography-based screening. Severe concerns regarding the mammography as the "golden standard" approach demanding complementary tools to cover the evident deficits led the authors to present innovative strategies, which would sufficiently improve the quality of the BC management and services to the patient. Contextually, this article provides insights into mammography deficits and current clinical data demonstrating the great potential of non-invasive diagnostic tools utilizing circulating miRNA profiles as an adjunct to conventional mammography for the population screening and personalization of BC management.

AB - In the global context, the epidemic of breast cancer (BC) is evident for the early 21st century. Evidence shows that national mammography screening programs have sufficiently reduced BC related mortality. Therefore, the great utility of the mammography-based screening is not an issue. However, both false positive and false negative BC diagnosis, excessive biopsies, and irradiation linked to mammography application, as well as sub-optimal mammography-based screening, such as in the case of high-dense breast tissue in young females, altogether increase awareness among the experts regarding the limitations of mammography-based screening. Severe concerns regarding the mammography as the "golden standard" approach demanding complementary tools to cover the evident deficits led the authors to present innovative strategies, which would sufficiently improve the quality of the BC management and services to the patient. Contextually, this article provides insights into mammography deficits and current clinical data demonstrating the great potential of non-invasive diagnostic tools utilizing circulating miRNA profiles as an adjunct to conventional mammography for the population screening and personalization of BC management.

KW - breast cancer

KW - individualized patient profile

KW - liquid biopsy

KW - mammography

KW - miRNA

KW - multi-level diagnostics

KW - omics

KW - personalized medicine

KW - predictive and preventive approach

KW - screening

UR - http://www.scopus.com/inward/record.url?scp=85068141313&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068141313&partnerID=8YFLogxK

U2 - 10.3390/ijms20122878

DO - 10.3390/ijms20122878

M3 - Review article

C2 - 31200461

AN - SCOPUS:85068141313

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 12

ER -